Open AccessCOVID-19 endocrinopathy with hindsight from SARS
Author(s) -
Kothandaraman Narasimhan,
Rengaraj Anantharaj,
Bai Xue,
Wen Shan Yew,
S. Sendhil Velan,
Neerja Karnani,
Melvin KheeShing Leow
Publication year - 2021
Publication title -
endocrinology and metabolism/american journal of physiology: endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 201
eISSN - 1522-1555
pISSN - 0193-1849
DOI - 10.1152/ajpendo.00480.2020
Subject(s) - covid-19 , pandemic , coronavirus , endocrine system , medicine , hindsight bias , intensive care medicine , hormone , virology , disease , outbreak , psychology , infectious disease (medical specialty) , cognitive psychology
The current COVID-19 pandemic is probably the worst the world has ever faced since the start of the new millennium. Although the respiratory system is the most prominent target of SARS-CoV-2 (the contagion of COVID-19), extrapulmonary involvement are emerging as important contributors of its morbidity and lethality. This article summarizes the impact of SARS-CoV and SARS-CoV-2 on the endocrine system to facilitate our understanding of the nature of coronavirus-associated endocrinopathy. Although new data are rapidly accumulating on this novel infection, many of the endocrine manifestations of COVID-19 remain incompletely elucidated. We, hereby, summarize various endocrine dysfunctions including coronavirus-induced new onset diabetes mellitus, hypocortisolism, thyroid hormone, and reproductive system aberrations so that clinicians armed with such insights can potentially benefit patients with COVID-19 at the bedside.